» Authors » Gaurav Choudhary

Gaurav Choudhary

Explore the profile of Gaurav Choudhary including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 145
Citations 2335
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehdi R, Mendiola E, Naeini V, Choudhary G, Avazmohammadi R
Annu Int Conf IEEE Eng Med Biol Soc . 2025 Mar; 2024:1-4. PMID: 40040040
Accurate assessment of myocardial tissue stiffness is pivotal for the diagnosis and prognosis of heart diseases. Left ventricular diastolic stiffness (β) obtained from the end-diastolic pressure-volume relationship (EDPVR) has conventionally...
2.
Neelakantan S, Vang A, Mehdi R, Phelan H, Nicely P, Imran T, et al.
J Am Heart Assoc . 2025 Feb; 14(5):e037126. PMID: 40008537
Background: Pulmonary hypertension (PH) results in increased right ventricular (RV) afterload, leading to RV dysfunction and failure. The mechanisms underlying maladaptive RV remodeling are poorly understood. In this study, we...
3.
Berkowitz J, Sagaityte E, Khalid M, Lopez D, Mohebali D, Bello N, et al.
Clin Res Cardiol . 2025 Feb; PMID: 39992386
Introduction: Understanding predictors of adverse outcomes in patients with peripartum cardiomyopathy (PPCM) is essential for risk stratification and prognosis. The aim of this study is to examine the relationship between...
4.
Roser S, Munarin F, Polucha C, Minor A, Choudhary G, Coulombe K
ACS Biomater Sci Eng . 2025 Feb; 11(3):1612-1628. PMID: 39945764
Therapeutic protein delivery has ushered in a promising new generation of disease treatment, garnering more recognition for its clinical potential than ever. However, proteins' limited stability, extremely short average half-lives,...
5.
Guo L, Khobragade N, Kieu S, Ilyas S, Nicely P, Asiedu E, et al.
J Am Heart Assoc . 2025 Feb; 14(3):e036882. PMID: 39895552
Background: Despite the poor outcomes related to the presence of pulmonary hypertension, it often goes undiagnosed in part because of low suspicion and screening tools not being easily accessible such...
6.
Li X, Hegarty K, Lin F, Chang J, Abdalla A, Dhanabalan K, et al.
Adv Sci (Weinh) . 2025 Jan; e2415824. PMID: 39799584
Pulmonary hypertension (PH) increases the mortality of preterm infants with bronchopulmonary dysplasia (BPD). There are no curative therapies for this disease. Lung endothelial carnitine palmitoyltransferase 1a (Cpt1a), the rate-limiting enzyme...
7.
Lee C, Khan R, Mantsounga C, Sharma S, Pierce J, Amelotte E, et al.
bioRxiv . 2025 Jan; PMID: 39763770
Coronavirus disease 2019 (COVID-19), caused by infection with the enveloped RNA betacoronavirus, SARS-CoV-2, led to a global pandemic involving over 7 million deaths. Macrophage inflammatory responses impact COVID-19 severity; however,...
8.
Forbes L, Bauer N, Bhadra A, Bogaard H, Choudhary G, Goss K, et al.
Pulm Circ . 2025 Jan; 15(1):e70027. PMID: 39749110
Pulmonary vascular disease is not a single condition; rather it can accompany a variety of pathologies that impact the pulmonary vasculature. Applying precision medicine strategies to better phenotype, diagnose, monitor,...
9.
Agraz M, Goksuluk D, Zhang P, Choi B, Clements R, Choudhary G, et al.
Front Genet . 2024 Oct; 15:1442759. PMID: 39399219
Introduction: The advent of RNA sequencing (RNA-Seq) has significantly advanced our understanding of the transcriptomic landscape, revealing intricate gene expression patterns across biological states and conditions. However, the complexity and...
10.
Neelakantan S, Mendiola E, Zambrano B, Vang A, Myers K, Zhang P, et al.
bioRxiv . 2024 Sep; PMID: 39229168
Pulmonary hypertension (PH) is defined as an elevation in the right ventricle (RV) afterload, characterized by increased hemodynamic pressure in the main pulmonary artery (PA). Elevations in RV afterload increase...